SOPH - PRICE - SOPHiA GENETICS SA

Serving as a valuation tool, the SOPH price chart demonstrates the dynamics of a business scaling an international AI-based B2B system for processing clinical data, reaching the 8.37 metric. Profit growth is driven by the proliferation of cloud software for oncogenetics and an increase in the number of paid tests. Simultaneously, SOPHiA GENETICS SA is reducing server energy costs by migrating to green data centers as part of its ESG agenda.

For SOPHiA GENETICS SA (SOPH), the market value of shares reflects a balance between the uniqueness of internal AI algorithms and the risks associated with dependence on external cloud data providers. This indicator captures the final monetary valuation of a single security per trading session, measuring market demand through the lens of expected returns. By analyzing changes in the security's price, an investor determines the sensitivity of the company's capitalization to technological and infrastructural news.